CN105582301A - 术后肿瘤患者抗副反应膏剂 - Google Patents
术后肿瘤患者抗副反应膏剂 Download PDFInfo
- Publication number
- CN105582301A CN105582301A CN201610117210.8A CN201610117210A CN105582301A CN 105582301 A CN105582301 A CN 105582301A CN 201610117210 A CN201610117210 A CN 201610117210A CN 105582301 A CN105582301 A CN 105582301A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- fry
- stir
- side reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 35
- 238000007086 side reaction Methods 0.000 title claims abstract description 33
- 230000002980 postoperative effect Effects 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 42
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 29
- 240000004980 Rheum officinale Species 0.000 claims abstract description 29
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 29
- 108010010803 Gelatin Proteins 0.000 claims abstract description 28
- 229920000159 gelatin Polymers 0.000 claims abstract description 28
- 239000008273 gelatin Substances 0.000 claims abstract description 28
- 235000019322 gelatine Nutrition 0.000 claims abstract description 28
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 28
- 241000735527 Eupatorium Species 0.000 claims abstract description 22
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 22
- 241001522129 Pinellia Species 0.000 claims abstract description 22
- 244000272264 Saussurea lappa Species 0.000 claims abstract description 22
- 235000006784 Saussurea lappa Nutrition 0.000 claims abstract description 22
- 239000000052 vinegar Substances 0.000 claims abstract description 22
- 235000021419 vinegar Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000132012 Atractylodes Species 0.000 claims description 21
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 21
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 15
- 240000007164 Salvia officinalis Species 0.000 claims description 13
- 235000005412 red sage Nutrition 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 8
- 235000002020 sage Nutrition 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 244000170916 Paeonia officinalis Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 description 24
- 208000024891 symptom Diseases 0.000 description 24
- 206010025482 malaise Diseases 0.000 description 21
- 241000736199 Paeonia Species 0.000 description 19
- 238000001959 radiotherapy Methods 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 11
- 230000036528 appetite Effects 0.000 description 9
- 235000019789 appetite Nutrition 0.000 description 9
- 239000002775 capsule Substances 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 241000545442 Radix Species 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000008187 granular material Substances 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 206010041349 Somnolence Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- -1 1.0 parts Substances 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 238000012752 Hepatectomy Methods 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011603 cardia cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 231100001157 chemotherapeutic toxicity Toxicity 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种术后肿瘤患者抗副反应膏剂,取下述重量配比的主要原料制备而成:黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。本发明所选材料均为传统中药材,无任何毒副作用;且药源易得,药材成本低廉,不会给患者造成负担。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种术后肿瘤患者抗副反应药剂及制备方法。
背景技术
化疗是目前肿瘤,尤其是恶性肿瘤患者最广泛采用的一种治疗方式。其原理在于:利用化学药物杀死肿瘤细胞、抑制肿瘤细胞的生长繁殖和促进肿瘤细胞的分化。放疗,即放射性治疗,是癌症三大治疗手段之一。是用各种不同能量的射线照射肿瘤,以抑制和杀灭癌细胞的一种治疗方法。放、化疗可以单独使用,也可以配合治疗,作为综合治疗的一部分,放、化疗可以提高肿瘤的治愈率。但是放、化疗属于“攻伐”的范围,往往会出现攻邪伤正的局面,放、化疗治疗肿瘤在杀伤肿瘤细胞的同时,也将正常细胞和免疫(抵抗)细胞一同杀灭,所以是一种"玉石俱焚"的治疗方法,因此放、化疗在治疗过程中多出现一些比较严重的毒副反应,对人体危害极大。
放、化疗的副反应表现为:
1.身体衰弱:患者在接受放、化疗后会出现身体疲乏无力、出虚汗,嗜睡等不适症状。
2.免疫功能下降:大多数有抗肿瘤作用的化疗药物对患者的免疫功能都有抑制作用,
在化疗后造成患者的免疫功能下降。
3.消化障碍:很多化疗药物通过刺激胃肠道的粘膜引发一系列的症状,如食欲下降、饮食量减少、恶心、呕吐、腹胀、腹痛、腹泻或便秘等。
4.神经系统毒素:主要是在接受化疗后,化疗药物对周围末梢神经产生损害作用,患者可出现肢端麻木,肢端感觉迟钝等症状。
5.皮肤异常:干性皮肤表现为皮肤瘙痒,色素沉着及脱皮,能产生永久浅褐色斑。湿性皮肤表现为照射部位湿疹、水泡,严重时可造成糜烂、破溃。
恶性肿瘤属于中医“积”、“虚劳”的范畴,存在着正虚邪实的表现。并且由于病程的绵延,会导致“久病及肾”的现象。在接受放、化疗之后,其正虚症候更加明显,因元气进一步受损可致:精神萎靡、全身乏力、五心烦热、少言懒语等。伤于胃则恶心纳呆,伤于肾则头晕耳鸣,齿落发脱,腰酸足软,伤于心则心悸气短。
公开号为CN101549154A(申请号200910031557.0)的中国专利文献公开了一种名为“一种抗辐射和减轻放疗副反应的营养液”,这种营养液由生理盐水加胡萝卜素、壳聚糖、维生素C、维生素E等制成。申请公布号为CN103446206A(申请号201210184710.5)的中国专利文献公开了一种名为“改善恶性肿瘤患者化疗所致毒副反应的组合物及应用”,该组合物是由灵芝5~200份、西洋参或人参5~150份、发酵虫草菌粉1~90份和/或冬虫夏草1~120份,或者由上述原料的水和/或醇提取物作活性成份组成的。公开号为CN1357354A(申请号01114965.5)的中国专利文献公开了一种名为“治疗恶性肿瘤放化疗副反应的药物及其制备方法”,其由党参、黄芪、茯苓、白术、女贞子、枸杞子、焦楂、甘草制成。
总之,中医中药在治疗放、化疗毒副反应方面取得了一定的成就,但也存在一些问题:现有肿瘤治疗制剂不能很好地解决化疗对人体的毒副反应,以至于很多肿瘤患者在治疗过程中已死于放、化疗的毒副反应,因此有待进一步提高完善。
发明内容
针对现有技术的不足,本发明的目的之一在于提供一种术后肿瘤患者抗副反应药剂,具有易操作、疗效显著的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的技术方案是:
术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成:黄芪20-30份,白术(麸炒)6-15份,白芍2-6份,丹参6-12份,川朴4-12份,大黄3-6份,阿胶5-12份,青黛3-6份,知母7-15份,香附(醋)4-8份,玉竹6-15份,广木香6-12份,佩兰3-9份,栀子(炒)3-6份,姜半夏4-12份。
术后肿瘤患者抗副反应药剂,优选的方案为,取下述重量配比的主要原料制备而成:黄芪13-16份,白术(麸炒)8-12份,白芍3-5份,丹参8-10份,川朴6-10份,大黄3-5份,阿胶7-10份,青黛4-6份,知母9-13份,香附(醋)5-7份,玉竹8-12份,广木香8-10份,佩兰5-7份,栀子(炒)4-6份,姜半夏7-9份。
术后肿瘤患者抗副反应药剂,更加优选的方案为,取下述重量配比的主要原料制备而成:黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
本发明还提供了将上述术后肿瘤患者抗副反应药剂制成药学上可接受的粉剂、水剂、膏剂、颗粒剂、片剂或胶囊。
所述粉剂的制备方法是:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过60-120目筛(优选的,过85-115目筛;更加优选的,过105目筛);
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏混合粉碎过85-135目筛(优选的,过100-120目筛;更加优选的,过110目筛);
(3)将步骤(1)和(2)所得混匀即可。
所述水剂的制备方法是:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过60-120目筛(优选的,过85-115目筛;更加优选的,过105目筛);
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的2.5-4.5倍(优选的,3-4倍;更加优选的,3.5倍))煎煮2次,第一次1.2-2.4小时(优选的,1.5-2.0小时;更加优选的,1.8小时),第二次0.8-1.2小时(优选的0.9-1.1小时;更加优选的,1.0小时),滤液合并,放冷;
(3)将步骤(1)粉碎后的大黄、青黛和阿胶加入步骤(2)所得药液,无菌封装。
所述膏剂的制备方法是:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过60-120目筛(优选的,过85-115目筛,更加优选的,过105目筛);
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的2.5-4.5倍(优选的,3-4倍;更加优选的,3.5倍))煎煮2次,第一次1.2-2.4小时(优选的,1.5-2.0小时;更加优选的,1.8小时),第二次0.8-1.2小时(优选的0.9-1.1小时;更加优选的,1.0小时),滤液合并,滤过,浓缩得相对密度为1.36-1.38(48℃)的清膏;
(3)将步骤(1)粉碎后的大黄、青黛和阿胶加入步骤(2)所得清膏,无菌封装。
所述颗粒剂的制备方法是:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过60-120目筛(优选的,过85-115目筛;更加优选的,过105目筛);
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的2.5-4.5倍(优选的,3-4倍;更加优选的,3.5倍))煎煮2次,第一次1.2-2.4小时(优选的,1.5-2.0小时;更加优选的,1.8小时),第二次0.8-1.2小时(优选的0.9-1.1小时;更加优选的,1.0小时),滤液合并,滤过,浓缩得相对密度为1.36-1.38(48℃)的清膏;
(3)取清膏0.8-1.2份(优选的,0.9-1.1份;更加优选的,1.0份),蔗糖1.5-3.5份(优选的,2-3份;更加优选的2.5份),糊精0.8-1.2份(优选的,0.9-1.1份;更加优选的,1.0份),混合后加步骤(1)所得大黄、青黛和阿胶细粉,混匀,制成颗粒,干燥,即得颗粒剂。
所述片剂的制备方法是:将权利要求5所得药剂粉剂按照0.3-0.5g/片(优选的,0.35-0.45g/片;更加优选的,0.4g/片)计量,按照片剂的加工制备方法压制成圆形或其他形状的片状剂型。
所述胶囊的制备方法是:将权利要求5所得药剂粉剂按照0.4-0.6g/粒(优选的,0.45-0.55g/粒;更加优选的,0.5g/粒)计量,按照胶囊的加工制备方法加工成胶囊状剂型。
本发明所用主要中药原料的药理如下:
黄芪:性味:味甘,温。归经:归肺、脾经。功效:益气升阳,固表止汗,利水消肿,托毒生肌。主治:一切气虚血亏之证,如脾虚泄泻,肺虚咳嗽,脱肛,子宫下垂,自汗,盗汗,水肿,血痹,痈疽难溃或久溃不敛。
白术(麸炒):性味:味苦、甘,温。归经:归脾、胃经。功效:健脾益气,燥湿利水,止汗,安胎。主治:脾气虚弱之乏力,食少腹胀,泄泻便秘,水饮内停之小便不利,水肿,痰饮眩晕,寒湿痹,身痛,气虚自汗,胎动不安。
白芍:性味:味苦,酸,微寒。归经:归肝、脾经。功效:养血合营,缓急止痛,敛阴平肝。主治:血虚寒热,脘腹疼痛,胁痛,肢体痉挛疼痛,痛经,月经不调,崩漏,自汗,盗汗,下痢泄泻,头痛眩晕。
丹参:性味:味苦,微寒。归经:归心、心包、肝经。功效:活血祛瘀,调经止痛,除烦安神,凉血消痈。主治:妇女月经不调,痛经,经闭,产后淤滞腹痛,心腹疼痛,癥瘕积聚,热痹肿痛,跌打损伤,热入营血,烦躁不安,心烦失眠,痈疮肿毒。
川朴:性味:味苦,辛,性温。归经:归脾、胃大肠经。功效:行气消积,燥湿除螨,降逆平喘。主治:食积气滞,腹胀便秘,湿阻中焦,脘痞吐泻,痰壅气逆,喘咳。
大黄:性味:味苦,寒。归经:胃、大肠、肝、脾经。功效:攻积滞,清湿热,泻火,凉血,祛瘀,解毒。主治:实积便秘,热结胸痞;湿热泻痢,黄疸,淋病,水肿腹满,小便不利;目赤,咽喉肿痛,口舌生疮,胃热呕吐,吐血,咯血,衄血,便血,尿血;蓄血,经闭,产后淤滞腹痛,癥瘕积聚,跌打损伤,热毒痈疡,丹毒,烫伤。
阿胶:性味:味甘,平。归经:归肝、肺、肾经。功效:补血止血,滋阴润肺。主治:血虚眩晕,吐血,衄血,便血,血痢,妊娠下血,崩漏,虚烦失眠,肺虚燥咳。
青黛:性味:味咸,寒。归经:归肝、肺、胃经。功效:清热,凉血,解毒。主治:温毒斑疹,吐血,衄血,咯血,小儿惊痫,肝火犯肺咳嗽,咽喉肿痛,丹毒,痄腮,疮肿,蛇虫咬伤。
知母:性味:味苦,寒。归经:归肺、胃、肾经。功效:清热泻火,滋阴润燥。主治:温热病高热烦渴,肺热咳嗽,骨蒸潮热,遗精,盗汗,虚烦不眠,消渴。
香附(醋):性味:味辛、甘、微苦,平。归经:归肝、三焦经。功效:理气解郁,调经,安胎。主治:胁肋胀痛,乳房胀痛,疝气疼痛,月经不调,脘腹痞满疼痛,嗳气吞酸,呕恶,经行腹痛,崩漏带下,胎动不安。
玉竹:性味:味甘,平。归经:归肺、胃经。功效:滋阴润肺,养胃生津。主治:燥咳,劳嗽,热病阴伤,咽干口渴,消渴,阴虚外感,头昏眩晕,筋脉挛痛。
广木香:性味:味辛、苦,温。归经:归肺、肝、脾经。功效:行气止痛,温中和胃。主治:胸腹胀痛,呕吐,泄泻,痢疾里急后重。
佩兰:性味:味辛,平。归经:归脾、胃经。功效:解暑化湿,醒脾和中。主治:暑湿或湿温初起,发热头重,胸闷腹胀,脘痞不饥,恶心呕吐,口中甜腻,消渴。
栀子(炒):性味:味苦,寒。归经:归心、肝、肺、胃、三焦经。功效:泻火除烦,清热利湿,凉血解毒。主治:热病心烦,肝火目赤,头痛,湿热黄疸,淋证,吐血,衄血,血痢,尿血,口舌生疮,疮疡肿毒,扭伤肿痛。
姜半夏:性味:味辛、温。归经:归脾、胃、肺经。功效:降逆止呕。主治:呕吐反胃,胸脘痞闷,梅核气。
本发明药剂基于中医中药治疗放、化疗副反应原理,是在研究了大量文献、药理工作和临床试验的基础上制成的。本发明所选材料均为传统中药材,无任何毒副作用,且本药剂完全按照中医药原则及肿瘤患者的身心特点,对放、化疗引起的副反应有很好的治疗效果。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成(每份10g):黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
上述术后肿瘤患者抗副反应药剂粉剂的制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏混合粉碎过110目筛;
(3)将步骤(1)和(2)所得混匀即可。
本发明粉剂服用方法:将粉剂分5g/袋,采用每天2-3次,每次一袋,用温开水冲服,7天一个疗程。
典型病例一蒋XX,年龄:45岁,性别:男。2009年8月在医院作贲门癌姑息切除术,术后一直接受化疗来缓解病痛,化疗引起了下列不适反应:食欲低下,全身乏力并伴有恶心呕吐现象,精神不振,做什么事都毫无精神,患者曾服用抗化疗副反应的药物,无明显治疗效果,严重影响了正常生活。服用本实施例所得术后肿瘤患者抗副反应药剂,采用每天3次,每次一袋,用温开水冲服,7天一个疗程。服用21天,患者食欲有所增强,不适症状缓解;服用2个月,患者恶心呕吐现象消失,精神、体力明显增强;继续服用两个月,不适症状完全消失,患者自感痊愈。
实施例2术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成(每份20g):黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
上述术后肿瘤患者抗副反应药剂膏剂的制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的3.5倍)煎煮2次,第一次1.8小时,第二次1.0小时,滤液合并,滤过,浓缩得相对密度为1.36-1.38(48℃)的清膏;
(3)将步骤(1)粉碎后的大黄、青黛和阿胶加入步骤(2)所得清膏,无菌封装。
本发明膏剂服用方法:膏剂采用每天2次,每次8-10g,按照1:10的比例冲水服用,7天一个疗程。
典型病例二杨XX,年龄:65岁,性别:女。2008年原发性肝癌破裂,急症剖腹,切除癌块,之后用化疗的方法治疗残癌,患者自述化疗会引起一些副反应,主要有:疲乏、免疫力低下、食欲不振、肢端感觉迟钝、精神萎靡等。服用本实施例所得术后肿瘤患者抗副反应药剂膏剂,采用每天2次,每次10g,按照1:10的比例冲水服用,7天一个疗程。服用15天,患者精神状态好转,食欲有所增强;服用1个月,免疫力提高,不适症状逐渐消失;继续服用2个月,患者服用时未出现任何不适,自感不适症状完全消失。
实施例3术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成(每份30g):黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
上述术后肿瘤患者抗副反应药剂颗粒剂的制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的3.5倍)煎煮2次,第一次1.8小时,第二次1.0小时,滤液合并,滤过,浓缩得相对密度为1.36-1.38(48℃)的清膏;
(3)取清膏1.0份,蔗糖2.5份,糊精1.0份,混合后加步骤(1)所得大黄、青黛和阿胶细粉,混匀,制成颗粒,干燥,即得颗粒剂。
本发明颗粒剂服用方法:将颗粒剂分10g/袋,每天2-3次,每次一袋,用温开水冲服,7天一个疗程。
典型病例三王XX,年龄:70岁,性别:男。患者做胃切除手术,之后一直做化疗进行治疗,患者自述每次化疗之后会出现以下不适症状:精神不振,无食欲,全身乏力,皮肤异常干燥,嗜睡等。服用本实施例所得术后肿瘤患者抗副反应药剂颗粒剂,采用每日3次,每次1一袋,用温开水冲服,7天一个疗程。服用10天,患者食欲有所增强,不适症状逐渐改善;服用1个月,患者体力增强,精神状态明显好转;继续服用2个月,不适症状消失。
实施例4术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成(每份40g):黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
上述术后肿瘤患者抗副反应药剂片剂的制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏混合粉碎过110目筛;
(3)将步骤(1)和(2)所得混匀得粉剂;
(4)将步骤(3)所得粉剂按照0.4g/片计量,按照片剂的加工制备方法压制成圆形或其他形状的片状剂型。
本发明片剂服用方法:片剂采用每天3次,每次5-8片,用温开水冲服,7天一个疗程。
典型病例四吴XX,年龄:63岁,性别:男。患者右下颌骨恶性肿瘤术后10年,2007年3月在医院诊断,右肺中叶有一孤立病灶,患者咳嗽,胸痛,诊断为肺癌转移,之后接受手术,术后通过放化疗来缓解病痛,但是放化疗引起一系列不适反应:肢端麻木、全身疲乏无力、食欲低下、嗜睡等。服用本实施例所得术后肿瘤患者抗副反应药剂片剂,采用每天3次,每次8片,用温开水冲服,7天一个疗程。服用7天,患者不适症状有所减轻,纳食渐多;服用2个月,不适症状逐渐消失,精神、体力明显增强;继续服用两个月,患者自感痊愈。
实施例5术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成(每份50g):黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
上述术后肿瘤患者抗副反应药剂胶囊剂的制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏混合粉碎过110目筛;
(3)将步骤(1)和(2)所得混匀得粉剂;
(4)将步骤(3)所得粉剂按照0.5g/粒计量,按照胶囊的加工制备方法加工成胶囊状剂型。
本发明胶囊剂服用方法:胶囊剂采用每天3次,每次6-10粒,用温开水冲服,7天一个疗程。
典型病例五方XX,年龄:49岁,性别:女。2007年5月胃部不适,自触及上腹部有鸡蛋大肿物,胃镜病理证实胃恶性淋巴瘤,术后接受放化疗来减少病痛,但是放化疗引起恶心呕吐、食欲不振、精神疲乏、免疫力低下等不适症状,服用过不少抗化疗副反应的药物,均无明显效果。服用本实施例所得术后肿瘤患者抗化疗副反应药剂,采用每天3次,每次10粒,服用14天,患者不适症状减轻,食欲增强;服用1个月,患者不适症状逐渐消失,精神状态好转,体力增强;继续服用2个月,患者自感无不适症状。
实施例6术后肿瘤患者抗副反应药剂,取下述重量配比的主要原料制备而成(每份60g):黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份。
上述术后肿瘤患者抗副反应药剂水剂的制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的3.5倍)煎煮2次,第一次1.8小时,第二次1.0小时,滤液合并,放冷;
(3)将步骤(1)粉碎后的大黄、青黛和阿胶加入步骤(2)所得药液,无菌封装。
本发明水剂服用方法:水剂采用每天2次(温热),每次300-500ml,7天一个疗程。
试验例1实施例6所得术后肿瘤患者抗副反应药剂水剂的临床应用:2008年7月-2012年5月,在8所医院筛选200例患者,其中女性96例,男性104例。试验之前2周,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组服用实施例6所得产品,对照组服用其它药品(康泰安口服液、硒维康等常规药品)。使用方法为:每天服用两次(温热),每次300m1-500m1(视具体情况有所调整),7天一个疗程。疗效情况判定标准:治愈:服用本品一个疗程,不适症状消失,精力及体力明显增强;有效:服用本品一个疗程,不适症状减轻或部分消失,精力及体力增强;无效:服用本品一个疗程,不适症状无变化。结果如表1所示。
表1:服用实施例6所得产品治疗效果验证
治疗效果:治愈72例(72%),有效26例(26%),无效2例(2%),总有效率98%。效果明显优于对照组。
服用期间自感症状及其体力精神变化如表2所示。
表2:
由表2可知:服用10天,52%以上的患者感到有所好转,不适症状改善;服用20天,73%以上的患者感到有所好转,不适症状改善或消失,精神、体力增强;服用30天,96%以上的感到有所好转,不适症状改善或消失,精神、体力增强,部分患者自感痊愈。实验组中服用30天以上,有效率可达94%,而对照组仅为75%。
最后应说明的是,实施例只是本发明最优的具体实施方式而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (1)
1.术后肿瘤患者抗副反应膏剂,其特征是,取下述重量配比的主要原料制备而成:黄芪15份,白术(麸炒)10份,白芍4份,丹参9份,川朴8份,大黄4份,阿胶8份,青黛5份,知母11份,香附(醋)6份,玉竹10份,广木香9份,佩兰6份,栀子(炒)5份,姜半夏8份;制备方法为:
(1)将大黄、青黛、阿胶分别粉碎成细粉,过105目筛;
(2)将黄芪、白术(麸炒)、白芍、丹参、川朴、知母、香附(醋)、玉竹、广木香、佩兰、栀子(炒)和姜半夏置于砂锅内,加水(用水量为原料药总重的3.5倍)煎煮2次,第一次1.8小时,第二次1.0小时,滤液合并,滤过,浓缩得相对密度为1.36-1.38(48℃)的清膏;
(3)将步骤(1)粉碎后的大黄、青黛和阿胶加入步骤(2)所得清膏,无菌封装。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410144868.9A CN103919995A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应药剂及制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410144868.9A Division CN103919995A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应药剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105582301A true CN105582301A (zh) | 2016-05-18 |
Family
ID=51138537
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610117210.8A Withdrawn CN105582301A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应膏剂 |
CN201610117212.7A Withdrawn CN105616963A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应药剂粉剂的制备方法 |
CN201410144868.9A Pending CN103919995A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应药剂及制备方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610117212.7A Withdrawn CN105616963A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应药剂粉剂的制备方法 |
CN201410144868.9A Pending CN103919995A (zh) | 2014-04-12 | 2014-04-12 | 术后肿瘤患者抗副反应药剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN105582301A (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106729282A (zh) * | 2016-12-28 | 2017-05-31 | 王于法 | 一种术后养胃的药物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8574636B2 (en) * | 2008-09-25 | 2013-11-05 | Lifebiotic Medical Research Ltd | Herbal formulations |
CN103550506B (zh) * | 2013-11-03 | 2015-10-28 | 崔合芳 | 一种用于放疗中配合使用的中药组合物 |
-
2014
- 2014-04-12 CN CN201610117210.8A patent/CN105582301A/zh not_active Withdrawn
- 2014-04-12 CN CN201610117212.7A patent/CN105616963A/zh not_active Withdrawn
- 2014-04-12 CN CN201410144868.9A patent/CN103919995A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN105616963A (zh) | 2016-06-01 |
CN103919995A (zh) | 2014-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101249235B (zh) | 治疗食道癌的中药及其制备方法 | |
CN103920034B (zh) | 减轻肿瘤病人化疗副反应的中药组合物及制法 | |
CN104940784A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN103041256A (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN103041257A (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN103908616B (zh) | 缓解肿瘤病人放疗反应的药剂及制备方法 | |
CN103041255A (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN105582301A (zh) | 术后肿瘤患者抗副反应膏剂 | |
CN105748911A (zh) | 术后肿瘤患者抗副反应胶囊剂的制备方法 | |
CN104083633A (zh) | 治疗肠功能紊乱的药剂及其制备方法 | |
CN103816468B (zh) | 一种治疗胃癌的胶囊及其制备方法 | |
CN104491182A (zh) | 减轻化疗副作用的中药药剂及制备方法 | |
CN103860960A (zh) | 一种治疗乳腺癌的胶囊及其制备方法 | |
CN104225506A (zh) | 用于治疗化疗后血小板减少的药物制剂 | |
CN103908579A (zh) | 抗化疗副反应的健脾和胃制剂及制法 | |
CN105641423A (zh) | 术后肿瘤患者抗副反应片剂 | |
CN105641424A (zh) | 术后肿瘤患者抗副反应颗粒剂 | |
CN103948758A (zh) | 甲状腺囊肿化痰散结的药剂及制备方法 | |
CN114869987A (zh) | 一种用于预防和治疗肝癌的中药组合物 | |
CN103041258A (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN107281336A (zh) | 一种治疗口腔疾病的中药及其制备方法 | |
CN104623137A (zh) | 中度脂肪肝通脉降脂中药组合物及制备方法 | |
CN104800740A (zh) | 适宜胃癌患者服用的药膳及制备方法 | |
CN103860991A (zh) | 急性心衰补气安神冲剂及制备方法 | |
CN103877461A (zh) | 心肌缺血温阳益气冲剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Qujing City, Yunnan Province, 655000 West Road No. 6 Xiyuan District Feng kylin District 2-2-601 Applicant after: Chen Xin Address before: 250014 Shandong City, Ji'nan province area of the liberation of East Road, No. 34, No. 5 modern Yi Building, unit 1001, 2 Applicant before: Chen Xin |
|
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160518 |
|
WW01 | Invention patent application withdrawn after publication |